A Phase III clinical trial including patients at the University of Oklahoma found that proton therapy improved survival and resulted in fewer side effects among people with head and neck cancer.
The trial was led by the University of Texas MD Anderson Cancer Center, enrolling 440 patients across 21 institutions.
It included oropharyngeal cancer patients, which includes the tonsils and the back part of the tongue. The incidence and mortality of oropharyngeal cancer have grown over the past three decades, particularly because of increases in HPV…